Cargando…

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer

OBJECTIVES: To investigative the predictive ability of radiomics signature for preoperative staging (I-IIvs.III-IV) of primary colorectal cancer (CRC). METHODS: This study consisted of 494 consecutive patients (training dataset: n=286; validation cohort, n=208) with stage I–IV CRC. A radiomics signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Cuishan, Huang, Yanqi, He, Lan, Chen, Xin, Ma, Zelan, Dong, Di, Tian, Jie, Liang, Changhong, Liu, Zaiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058766/
https://www.ncbi.nlm.nih.gov/pubmed/27120787
http://dx.doi.org/10.18632/oncotarget.8919
_version_ 1782459300919115776
author Liang, Cuishan
Huang, Yanqi
He, Lan
Chen, Xin
Ma, Zelan
Dong, Di
Tian, Jie
Liang, Changhong
Liu, Zaiyi
author_facet Liang, Cuishan
Huang, Yanqi
He, Lan
Chen, Xin
Ma, Zelan
Dong, Di
Tian, Jie
Liang, Changhong
Liu, Zaiyi
author_sort Liang, Cuishan
collection PubMed
description OBJECTIVES: To investigative the predictive ability of radiomics signature for preoperative staging (I-IIvs.III-IV) of primary colorectal cancer (CRC). METHODS: This study consisted of 494 consecutive patients (training dataset: n=286; validation cohort, n=208) with stage I–IV CRC. A radiomics signature was generated using LASSO logistic regression model. Association between radiomics signature and CRC staging was explored. The classification performance of the radiomics signature was explored with respect to the receiver operating characteristics(ROC) curve. RESULTS: The 16-feature-based radiomics signature was an independent predictor for staging of CRC, which could successfully categorize CRC into stage I-II and III-IV (p <0.0001) in training and validation dataset. The median of radiomics signature of stage III-IV was higher than stage I-II in the training and validation dataset. As for the classification performance of the radiomics signature in CRC staging, the AUC was 0.792(95%CI:0.741-0.853) with sensitivity of 0.629 and specificity of 0.874. The signature in the validation dataset obtained an AUC of 0.708(95%CI:0.698-0.718) with sensitivity of 0.611 and specificity of 0.680. CONCLUSIONS: A radiomics signature was developed and validated to be a significant predictor for discrimination of stage I-II from III-IV CRC, which may serve as a complementary tool for the preoperative tumor staging in CRC.
format Online
Article
Text
id pubmed-5058766
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50587662016-10-15 The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer Liang, Cuishan Huang, Yanqi He, Lan Chen, Xin Ma, Zelan Dong, Di Tian, Jie Liang, Changhong Liu, Zaiyi Oncotarget Research Paper OBJECTIVES: To investigative the predictive ability of radiomics signature for preoperative staging (I-IIvs.III-IV) of primary colorectal cancer (CRC). METHODS: This study consisted of 494 consecutive patients (training dataset: n=286; validation cohort, n=208) with stage I–IV CRC. A radiomics signature was generated using LASSO logistic regression model. Association between radiomics signature and CRC staging was explored. The classification performance of the radiomics signature was explored with respect to the receiver operating characteristics(ROC) curve. RESULTS: The 16-feature-based radiomics signature was an independent predictor for staging of CRC, which could successfully categorize CRC into stage I-II and III-IV (p <0.0001) in training and validation dataset. The median of radiomics signature of stage III-IV was higher than stage I-II in the training and validation dataset. As for the classification performance of the radiomics signature in CRC staging, the AUC was 0.792(95%CI:0.741-0.853) with sensitivity of 0.629 and specificity of 0.874. The signature in the validation dataset obtained an AUC of 0.708(95%CI:0.698-0.718) with sensitivity of 0.611 and specificity of 0.680. CONCLUSIONS: A radiomics signature was developed and validated to be a significant predictor for discrimination of stage I-II from III-IV CRC, which may serve as a complementary tool for the preoperative tumor staging in CRC. Impact Journals LLC 2016-04-22 /pmc/articles/PMC5058766/ /pubmed/27120787 http://dx.doi.org/10.18632/oncotarget.8919 Text en Copyright: © 2016 Liang et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Liang, Cuishan
Huang, Yanqi
He, Lan
Chen, Xin
Ma, Zelan
Dong, Di
Tian, Jie
Liang, Changhong
Liu, Zaiyi
The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
title The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
title_full The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
title_fullStr The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
title_full_unstemmed The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
title_short The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
title_sort development and validation of a ct-based radiomics signature for the preoperative discrimination of stage i-ii and stage iii-iv colorectal cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058766/
https://www.ncbi.nlm.nih.gov/pubmed/27120787
http://dx.doi.org/10.18632/oncotarget.8919
work_keys_str_mv AT liangcuishan thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT huangyanqi thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT helan thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT chenxin thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT mazelan thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT dongdi thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT tianjie thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT liangchanghong thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT liuzaiyi thedevelopmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT liangcuishan developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT huangyanqi developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT helan developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT chenxin developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT mazelan developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT dongdi developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT tianjie developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT liangchanghong developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer
AT liuzaiyi developmentandvalidationofactbasedradiomicssignatureforthepreoperativediscriminationofstageiiiandstageiiiivcolorectalcancer